Operational Highlights and Financial Results for the Period Ended March 31, 2022 – GlobeNewswire

Chronic Low Back Pain … FDA agreed with Mesoblast's proposal for pain reduction at 12 months as the primary endpoint of the next trial, …
Source: back pain